Roush W. Dana-Farber death sends a warning to research hospitals. Science 1995 Jul 21;269(5222):295-6 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/7618095.
Compare quality appraisals for each clinical question
- What governance processes, policies and procedures should be in place for the safe provision of cancer therapy?
- What special considerations are required for clinical trials or special access schemes for cancer therapy?